Alzheimer’s and Antipsychotics: Investigating Neuroprotective and Behavioural Outcomes in Rats | ||
| Egyptian Journal of Chemistry | ||
| Volume 68, Issue 13, December 2025, Pages 889-902 PDF (4.16 M) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejchem.2025.373645.11559 | ||
| Authors | ||
| Soha Mohamed Hamdy1; Sara Ahmed Mahmoud Seadawy* 2; Amany M Shabaan3; Weaam Gouda4; Mie Afify4; Nermeen Mohamed Shaffie5; Eman Refaat Youness6; Omar Abdel-Salam7 | ||
| 1Department of Chemistry, Biochemistry Division, Faculty of Science, Fayoum University, El-Fayoum, Egypt | ||
| 2Affiliation 1: Chemistry department, Biochemistry division, Faculty of Science, El Fayoum University, El Fayoum, Egypt. Affiliation 2: Biochemistry Department, Biotechnology Research Institute, National Research Centre, Giza, Egypt. | ||
| 3Chemistry department, Biochemistry division, Faculty of Science, El Fayoum University, El Fayoum, Egypt. | ||
| 4Biochemistry Department, Biotechnology Research Institute, National Research Centre, Giza, Egypt | ||
| 5Pathology Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt | ||
| 6Medical Biochemistry Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt. | ||
| 7Narcotics, Ergogenic aid &Poisons department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt. | ||
| Abstract | ||
| Alzheimer’s disease (AD) remains the leading cause of dementia in the elderly, with no definitive cure. Recently, antipsychotic drugs (APDs) have shown effectiveness in managing neuropsychiatric symptoms liked those associated with AD. This study investigated the neurobiological effects of traditional APDs (chlorpromazine and haloperidol) and modern APDs (clozapine and olanzapine) on oxidative stress, neuroinflammation, neuronal injury, and cognitive-behavioral symptoms in an aluminum chloride (AlCl₃)-induced rat model of AD. Sixty adult male rats were divided into ten groups: a saline control, an AlCl₃-only group, and eight groups received AlCl₃ (10 mg/kg/day) for two months, alongside APDs at 1.5 or 3 mg/kg during the second month. At the end of the second month, behavioral responses were examined via the open field test, followed by immunohistopathological and biochemical assessments. A colorimetric spectrophotometer was used to determine the levels of malondialdehyde, nitric oxide, paraoxonase 1, and acetylcholinesterase. Meanwhile, the levels of reduced glutathione, monocyte chemoattractant protein-1, interleukin-1 beta, amyloid-beta peptide, and neuron-specific enolase were determined using an enzyme-linked immunosorbent assay. APDs mitigated AlCl₃-induced AD-like symptoms by improving behavioral deficits and reducing oxidative stress, neuroinflammation, neuronal injury, and acetylcholinesterase activity, with modern types enhancing cognition and behavior, while traditional ones exhibiting stronger antioxidant effects. | ||
| Keywords | ||
| Aluminum chloride; clozapine; olanzapine; chlorpromazine; haloperidol; Alzheimer' s disease | ||
|
Statistics Article View: 142 PDF Download: 11 |
||
